Erytech
is a France-based clinical-stage biopharmaceutical company that researches and develops red blood cell therapeutics for the treatment of cancer... Read moreErytech
is a France-based clinical-stage biopharmaceutical company that researches and develops red blood cell therapeutics for the treatment of cancer... Read more
News
Sep 21, 2023
Marketscreener
Erytech: PHAXIAM Therapeutics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
Sep 19, 2023
Americanbankingnews
Erytech: PHAXIAM Therapeutics (PHXM) Scheduled to Post Earnings on Thursday
Sep 18, 2023
MarketScreener
Erytech: PHAXIAM Therapeutics announces the completion of its reverse share split
Sep 08, 2023
StreetInsider
Press Release: Erytech : Monthly information related to total number of voting rights and shares composing the share capital _August 31, 2023
Aug 08, 2023
FinanzNachrichten
Erytech: Erytech Pharma S.A.: Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2023
Jul 27, 2023
FinanzNachrichten
Erytech: Erytech Pharma S.A.: PHAXIAM Therapeutics announces a reverse share split of its shares
Jun 28, 2023
FinanzNachrichten
Erytech: Erytech Pharma S.A.: Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM
Jun 26, 2023
BioSpace
Erytech: ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
Jun 24, 2023
Life Care News
Erytech: ERYTECH announces the approval of the merger with
Jun 13, 2023
Benzinga
Erytech: Erytech's Battle With Activist Investor Echoes As Pherecydes Pharma Merger Vote Comes Closer
Erytech Competitors
1
2
3
4
5
6
7
8
9
10